Joerg Scheier
Overview
Explore the profile of Joerg Scheier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
77
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Taccone F, Brunkhorst F, Bottari G, Hidalgo J, Kribben A, Teboul J, et al.
JMIR Res Protoc
. 2024 Nov;
13:e55880.
PMID: 39500494
Background: Extracorporeal blood purification with CytoSorb has been increasingly used as an adjunctive therapy in several hyperinflammatory critical care conditions, as well as to remove elevated levels of myoglobin or...
2.
Leber B, Liebchen U, Rohrhofer L, Weber J, Klaus T, Scheier J, et al.
Front Med (Lausanne)
. 2023 Nov;
10:1258661.
PMID: 37928476
Introduction: Hemoadsorption shows promising signals in organ preservation and post lung transplantation. However, its potential impact on the pharmacokinetics of immunosuppressant drugs (ID) is still unknown. Methods: In this interventional...
3.
Awori Hayanga J, Song T, Durham L, Garrison L, Smith D, Molnar Z, et al.
Crit Care
. 2023 Jun;
27(1):243.
PMID: 37337243
Objectives: The CytoSorb therapy in COVID-19 (CTC) registry evaluated the clinical performance and treatment parameters of extracorporeal hemoadsorption integrated with veno-venous extracorporeal membrane oxygenation (VV ECMO) in critically ill COVID-19...
4.
Akil A, Napp L, Rao C, Klaus T, Scheier J, Pappalardo F
J Clin Med
. 2022 Oct;
11(20).
PMID: 36294309
Acute respiratory distress syndrome (ARDS) is associated with high morbidity and mortality. Adjunct hemoadsorption is increasingly utilized to target underlying hyperinflammation derived from ARDS. This article aims to review available...
5.
Scheier J, Nelson P, Schneider A, Colombier S, Kindgen-Milles D, Deliargyris E, et al.
Crit Care Explor
. 2022 Jul;
4(5):e0688.
PMID: 35783552
Data Sources: Detailed search strategy using the PubMed and OVID MEDLINE databases, as well as presented congress abstracts for studies on drug removal by the CytoSorb device. Study Selection: Human,...
6.
Hawchar F, Rao C, Akil A, Mehta Y, Rugg C, Scheier J, et al.
Biomedicines
. 2021 Aug;
9(7).
PMID: 34356830
Hemodynamic instability due to dysregulated host response is a life-threatening condition requiring vasopressors and vital organ support. Hemoadsorption with Cytosorb has proven to be effective in reducing cytokines and possibly...
7.
Schneider A, Andre P, Scheier J, Schmidt M, Ziervogel H, Buclin T, et al.
Sci Rep
. 2021 May;
11(1):10493.
PMID: 34006946
Cytokine hemoadsorption might be beneficial in patients with sepsis. However, its effect on anti-infective agents' disposition remains largely unknown. We sought to determine the influence of hemoadsorption on the pharmacokinetics...